EX-10.1






Exhibit 10.1




	 
	 

	SIPEX CORPORATION

	 

	as the Company

	 

	 

	and

	 

	RODFRE HOLDINGS LLC,

	 

	as the Purchaser

	 

	SECURITIES PURCHASE AGREEMENT

	 

	 

	Dated as of January 19, 2006







1



TABLE OF CONTENTS




Page




	 	 	 	 	 
	SECTION 1. Purchase and Sale of Note
	 	 	1	 
	SECTION 2. Purchaser’s Representations and Warranties
	 	 	2	 
	SECTION 3. Representations, Warranties and Covenants of the Company
	 	 	5	 
	SECTION 4. Covenants
	 	 	11	 
	SECTION 5. Conditions to the Company’s Obligation to Close
	 	 	13	 
	SECTION 6. Conditions to Purchaser’s Obligation to Purchase
	 	 	14	 
	SECTION 7. Miscellaneous
	 	 	16	 






SCHEDULE




Schedule A Wire Instructions



EXHIBITS




	 	 	 
	Exhibit A

	 	Form of Note
	 

	 	

	Exhibit B

	 	Form of Deed of Trust
	 

	 	

	Exhibit C

	 	Secretary’s Certificate
	 

	 	







 



2




SECURITIES PURCHASE AGREEMENT




THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 19, 2006, by
and between Sipex Corporation, a Delaware corporation (the “Company”), and Rodfre Holdings
LLC (the “Purchaser”), a Delaware Limited Liability Company.



THE PARTIES TO THIS AGREEMENT enter into this Agreement on the basis of the following facts,
intentions and understandings:



A. In accordance with the terms and conditions of this Agreement, the Company has agreed to
issue and sell, and the Purchaser has agreed to purchase the Company’s 9% Secured Note with
convertible interest due January, 2008 in an aggregate amount of U.S. $7,000,000 (the
“Principal Amount”) (such note, in the form attached hereto as Exhibit A, as the
same may be amended, modified or supplemented from time to time in accordance with the terms
thereof, the “Note”) The annual Interest of the Note shall be, at the option of the
Purchaser, convertible into shares of the common stock, $0.01 par value per share (the “Common
Stock”), of the Company on the terms set forth in the Note. The shares of Common Stock
issuable upon conversion of the accrued Interest on the Note are referred to herein collectively as
the “Conversion Shares.” The Note and the Conversion Shares are referred to herein as the
“Securities.”



B. This Agreement and the Note, and each of the other agreements entered into by the parties
hereto in connection with the transactions contemplated by this Agreement (the
“Transaction”) are referred to herein collectively as the “Transaction Documents.”



NOW THEREFORE, in consideration of the promises and the mutual covenants contained herein and
other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Company and the Purchaser hereby agree as follows:



SECTION 1. Purchase and Sale of Note. (a) Closing of Note. (1) Upon the satisfaction (or
written waiver) of the conditions set forth in Sections 5 and 6 of this Agreement, the Company
shall issue and sell to Purchaser, and Purchaser agrees to purchase from the Company, the Note (the
“Closing”). The price to be paid by the Purchaser for the Note shall be $7,000,000 USD.



(2) The date and time of the Closing (the “Closing Date”) shall be 8:00 a.m.,
California time, on January 19, 2006 (or such other date as the parties may specify), subject to
the satisfaction (or waiver) of the conditions set forth in Sections 6 and 7 of this Agreement.
The Closing shall occur on the Closing Date at the offices of Wilson Sonsini Goodrich & Rosati, 650
Page Mill Road, Palo Alto, California 94304 or at such other places as the parties may agree.



(b) Form of Payment. On the Closing Date, (i) Purchaser shall pay the Company for the Note to
be issued and sold to such Purchaser on such Closing Date, by wire transfer of immediately
available funds in accordance with the Company’s written wire instructions attached hereto on
Schedule A, and (ii) the Company shall deliver to Purchaser a properly authenticated Note
representing the principal amount of the Note , duly executed on behalf of the Company and
registered in the name of the Purchaser, that the Purchaser is purchasing from the Company pursuant
to this Agreement.SECTION 2. Purchaser’s Representations and WarrantiesPurchaser represents and
warrants to the Company that as of the date hereof and the Closing Date:



(a) Investment Purpose. Purchaser is acquiring the Note and upon conversion of the Note owned
by it, will acquire the Conversion Shares then issuable upon conversion thereof, for its own
account for investment only and not with a view toward, or for resale in connection with, the
public sale or distribution thereof, except pursuant to sales or distributions registered or
exempted under the Securities Act.



(b) Accredited Investor Status. Purchaser is an “accredited investor” as that term is
defined in Rule 501(a) of Regulation D under the Securities Act as of the date of this Agreement.



(c) Reliance on Exemptions. Purchaser understands that the Securities are being offered and
sold to it in reliance on specific exemptions from the registration requirements of the United
States federal and state securities laws and that the Company is relying in part upon the truth and
accuracy of, and Purchaser’s compliance with, the representations, warranties, agreements,
acknowledgments and understandings of Purchaser set forth herein and in the Note in order to
determine the availability of such exemptions and the eligibility of Purchaser to acquire the
Securities.



(d) Information. Purchaser believes it (i) has been furnished with or believes it has had
full access to all of the information that it considers necessary or appropriate for deciding
whether to purchase the Securities, (ii) has had an opportunity to ask questions and receive
answers from the Company regarding the terms and conditions of the offering of the Securities,
(iii) can bear the economic risk of a total loss of its investment in the Securities and (iv) has
such knowledge and experience in business and financial matters so as to enable it to understand
the risks of and form an investment decision with respect to its investment in the Securities.
Neither such inquiries nor any other due diligence investigations conducted by Purchaser or its
advisors, if any, or its representatives shall limit, modify, amend or affect the Company’s
representations and warranties contained in this Agreement and the Purchaser’s right to rely
thereon.



(e) No Governmental Review. Purchaser understands that no United States federal or state
agency or any other government or governmental agency has passed on or made any recommendation or
endorsement of the Securities or the fairness or suitability of an investment in the Securities nor
have such authorities passed upon or endorsed the merits of the offering of the Securities.



(f) Transfer or Resale. Purchaser understands that, except as provided in Section 5 herein,
none of the Securities have been or will be registered under the Securities Act or any state
securities laws, and the Securities may not be offered for sale, sold, assigned or transferred
without registration under the Securities Act or an exemption therefrom and that, in the absence of
an effective registration statement under the Securities Act, such Securities may only be sold
under certain circumstances as set forth in the Securities Act, it being understood that
nothing in this Agreement shall restrict any transfer of Securities to (a) the Company or (b) an
affiliate of the holder of such Securities (provided that in the case of (b) above the transferor
furnishes the Company with such certifications, legal opinions or other information as the Company
may reasonably request to confirm that such transfer is being made pursuant to an exemption from,
or in a transaction not subject to, the registration requirements of the Securities Act).



(g) Legends.



(1) Purchaser understands that, until the later of (i) the end of the holding period under
Rule 144(k) of the Securities Act (or any successor provision) and (ii) such time as Purchaser
ceases to be an “affiliate” of the Company as such term is defined in Rule 144 of the Securities
Act, the Note (and all securities issued in exchange therefor or in substitution thereof, other
than Conversion Shares, which shall bear the legend set forth in Section 2(g)(2) of this Agreement,
if applicable) shall bear a legend in substantially the following form:



THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS.
THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, ASSIGNED,
PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION THEREFROM.



The legend set forth above shall be removed and the Company shall issue a new Note of like
tenor and aggregate principal amount and which shall not bear the restrictive legends required by
this Section 2(g)(1), (i) if, in connection with a sale transaction, such holder provides the
Company with an opinion of counsel reasonably acceptable to the Company to the effect that a public
sale, assignment, pledge or transfer of the Note may be made without registration under the
Securities Act, or (ii) upon expiration of the two-year holding period under Rule 144(k) of the
Securities Act (or any successor rule). The Company shall not require such opinion of counsel for
the sale of Securities in accordance with Rule 144 of the Securities Act in the event that the
Seller provides such representations that the Company shall reasonably request confirming
compliance with the requirements of Rule 144.



(2) Such Purchaser understands that, until the later of (i) the end of the holding period
under Rule 144(k) of the Securities Act (or any successor provision) with respect to the Conversion
Shares issued upon any conversion of the Note, and (ii) such time as Purchaser ceases to be an
“affiliate” of the Company as such term is defined in Rule 144 of the Securities Act, any stock
certificate representing Conversion Shares issued upon such conversion of the Note shall bear a
legend in substantially the following form unless the Note submitted for conversion, does not bear
the legend specified in Section 2(g)(1):



THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR AN EXEMPTION THEREFROM.



The legend set forth above shall be removed and the Company shall issue the Conversion Shares
without such legend to the holder of the Conversion Shares upon which it is stamped, (i) if such
Conversion Shares have been resold or transferred pursuant to the registration statement
contemplated by Section 5 herein and the registration statement was effective at the time of such
transfer, (ii) if, in connection with a sale transaction, such holder provides the Company with an
opinion of counsel reasonably acceptable to the Company to the effect that a public sale,
assignment, pledge or transfer of the Conversion Shares may be made without registration under the
Securities Act, or (iii) upon the later of (a) expiration of the two-year period under Rule 144(k)
of the Securities Act (or any successor rule) and (b) such time as Purchaser ceases to be an
“affiliate” of the Company as such term is defined in Rule 144 of the Securities Act. The Company
shall not require such opinion of counsel for the sale of Conversion Shares in accordance with Rule
144 of the Securities Act, provided that the Seller provides such representations that the Company
shall reasonably request confirming compliance with the requirements of Rule 144.



(3) Purchaser understands that, in the event Rule 144(k) as promulgated under the Securities
Act (or any successor rule) is amended to change the two-year period under Rule 144(k) (or the
corresponding period under any successor rule), (i) each reference in Sections 2(g)(1) and 2(g)(2)
of this Agreement to “two (2) years”, the “two-year period” or “two-year
holding period” shall be deemed for all purposes of this Agreement to be references to such
changed period, and (ii) all corresponding references in the Note shall be deemed for all purposes
to be references to the changed period, provided that such changes shall not become effective if
they are otherwise prohibited by, or would otherwise cause a violation of, the then-applicable
federal securities laws.



(h) Authorization; Enforcement; Validity. The Transaction Documents have been duly and
validly authorized, executed and delivered on behalf of Purchaser and are valid and binding
agreements of Purchaser enforceable against Purchaser in accordance with their terms, subject as to
enforceability to general principles of equity (regardless of whether such enforceability is
considered in a proceeding in equity or at law) and to applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally,
the enforcement of applicable creditors’ rights and remedies and except as the indemnification
agreements of Purchaser may be legally unenforceable.



(i) Residency. Purchaser is a resident of that country or state specified in its address on
the signature page hereto and executed by it.



(j) Additional Acknowledgement. Purchaser acknowledges that it has independently evaluated
the merits of the transactions contemplated by this Agreement and the Note and that it has
independently determined to enter into the transactions contemplated hereby and thereby.



With the exception of Section 2(h), the Purchaser’s representations and warranties made in
this Section 2 are made solely for the purpose of permitting the Company to make a determination
that the offer and sale of the Note pursuant to this Agreement complies with applicable United
States federal and state securities laws and not for any other purpose. Accordingly, other than
Section 2(h), the Company should not rely on such representations and warranties for any other
purpose.



SECTION 3. Representations, Warranties and Covenants of the CompanyThe Company hereby
represents and warrants to, and covenants with, the Purchaser that as of the date hereof subject to
such exceptions as set forth in the letter from the Company to Purchaser dated as of the date
hereof (the “Disclosure Letter”):



(a) Organization. The Company is duly organized and validly existing in good standing under
the laws of the jurisdiction of its organization. Each of the Company and its subsidiaries listed
on Exhibit 21.1 to its Annual Report on Form 10-K for the year ended December 31, 2003 (the
“Subsidiaries”) has full power and authority to own, operate and occupy its properties and
to conduct its business as presently conducted and as described in the Company’s Annual Report on
Form 10-K for the year ended December 31, 2003, including all exhibits, supplements and amendments
thereto, and the Company’s Quarterly Report on Form 10-Q for the quarter ended October 2, 2004,
including all exhibits, supplements and amendments thereto and current report on Form 8-K (the
“SEC Filings”), and is registered or qualified to do business and in good standing in each
jurisdiction in which the failure to be so qualified would have a Material Adverse Effect, and to
the Company’s knowledge, no proceeding has been instituted in any such jurisdiction, revoking,
limiting or curtailing, or seeking to revoke, limit or curtail, such power and authority or
qualification. As used in this Agreement, “Material Adverse Effect” means any material adverse
effect upon (i) the business, financial condition, results of operations, assets, properties or
operations of the Company and its Subsidiaries, considered as one enterprise, or (ii) the Company’s
ability to perform its obligations under this Agreement. No subsidiary of the Company is a
“significant subsidiary” of the Company as such term is defined in Rule 1-02(w) of Regulation S-X.



(b) Due Authorization and Valid Issuance. Except as set forth in Section 3(b) of the
Disclosure Letter, the Company has all requisite power and authority to execute, deliver and
perform its obligations under the Transaction Documents, and the Transaction Documents and the
transactions contemplated thereby have been duly authorized by the Company and its Board of
Directors and no further consent or authorization by the Company, or its shareholders is required.
Each of the Transaction Documents has been validly executed and delivered by the Company and
constitutes the legal, valid and binding agreement of the Company enforceable against the Company
in accordance with its terms, except as rights to indemnity and contribution may be limited by
state or federal securities laws or the public policy underlying such laws, except as
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting creditors’ and contracting parties’ rights generally and except as
enforceability may be subject to general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or at law). The Note being purchased by the
Purchaser hereunder will, upon issuance pursuant to the terms hereof, be duly authorized, validly
issued, fully paid and nonassessable, and shall be free from all liens, claims and encumbrances,
except encumbrances or restrictions arising under U.S. federal or state securities laws, with
respect to the issuance thereof, and the Purchaser shall be entitled to all the rights set forth
therein.



(c) Non-Contravention. The execution, delivery and performance of the Transaction Documents,
including without limitation the issuance and sale of the Note to be sold by the Company under the
Transaction Documents, the fulfillment of the terms of the Transaction Documents and the
consummation of the transactions contemplated thereby, will not constitute a violation of, or
default (with the passage of time or otherwise) under (i) any bond, debenture, note or other
evidence of indebtedness, lease, contract, indenture, mortgage, deed of trust, loan agreement,
joint venture or other agreement or instrument to which the Company or any Subsidiary is a party or
by which it or any of its Subsidiaries or their respective properties are bound when such
violation, conflict or default, individually, or in the aggregate, would have a Material Adverse
Effect, (ii) the articles of organization, by-laws or other organizational documents of the Company
or any Subsidiary, or (iii) any law, administrative regulation, ordinance or order of any court or
governmental agency, arbitration panel or authority applicable to the Company or any Subsidiary or
their respective properties when such violation, conflict or default would have a Material Adverse
Effect. In addition, the execution, delivery and performance of the Transaction Documents,
including without limitation the issuance and sale of the Note to be sold by the Company under the
Transaction Documents, the fulfillment of the terms of the Transaction Documents and the
consummation of the transactions contemplated thereby, will not result in the creation or
imposition of any lien, encumbrance, claim, security interest or restriction whatsoever upon any of
the properties or assets of the Company or any Subsidiary (other than (i) the lien of the Deed of
Trust on the property to be subject to the Deed of Trust or (ii) an acceleration of indebtedness
pursuant to any obligation, agreement or condition contained in any bond, debenture, note or any
other evidence of indebtedness or any indenture, mortgage, deed of trust or any other agreement or
instrument to which the Company or any Subsidiary is a party or by which any of them is bound or to
which any of the property or assets of the Company or any Subsidiary is subject where such lien or
other restriction would have a Material Adverse Effect. Except for such filings and clearances, if
any, as may be required by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended
(the “HSR Act”), no consent, approval, authorization or other order of, or registration,
qualification or filing with, any regulatory body, administrative agency, or other governmental
body in the United States or any other person is required for the execution, delivery and
performance of the Transaction Documents, including without limitation the valid issuance and sale
of the Securities to be sold pursuant to the Transaction Documents, other than such as have been
made or obtained, and except for any post-closing securities filings or notifications required to
be made under federal or state securities laws. Assuming the accuracy of the representations made
by Purchaser in Section 2, the issuance by the Company of the Note is exempt from registration
under the Securities Act and the issuance of the Conversion Shares upon conversion the Note, will
be exempt from registration under the Securities Act under applicable rules and regulations as
currently in effect.



(d) Capitalization. The Company’s authorized capital stock as of January 11, 2006 consisted
of (i) 60,000,000 shares of Common Stock, $0.01 par value per share, of which 35,550,378 shares are
issued and outstanding, 4,507,521 are reserved for issuance under the Company’s 1994 Stock Option
and Incentive Plan, 1996 Stock Option and Incentive Plan, 1996 Non-Employee Director Stock Option
Plan, 1997 Incentive Stock Option Plan, Sipex Corporation 1999 Stock Plan, 2000 Non-Qualified Stock
Option Plan, 2002 Nonstatutory Stock Option Plan, and 1996 Employee Stock Purchase Plan (such plans
collectively, “Employee Benefit Plans”), 3,144,274 shares are reserved for issuance
pursuant to options outside the Employee Benefit Plans, and (ii) 1,000,000 shares of Preferred
Stock, $0.01 par value per share, of which no shares are issued and outstanding. The Company has
not issued any capital stock since that date other than pursuant to (i) the Employee Benefit Plans,
or (ii) upon exercise of outstanding warrants or options disclosed in the SEC Filings. The Company
has no stock option or stock purchase plans or other equity incentive plans of any kind other than
the Employee Benefit Plans. The Conversion Shares to be issued by the Company pursuant to the
Transaction Documents have been duly authorized, and when issued in accordance with the terms of
the Transaction Documents, will be duly and validly issued, fully paid and nonassessable and will
be free from all taxes, liens and charges with respect to the issuance thereof, with the holder
thereof entitled to all rights accorded to holders of Common Stock of the Company, generally. The
outstanding shares of capital stock of the Company have been duly and validly issued and are fully
paid and nonassessable, have been issued in compliance with all federal and state securities laws,
and were not issued in violation of any preemptive rights or similar rights to subscribe for or
purchase securities. Except as set forth herein or in the SEC Filings, there are no (i)
outstanding rights (including, without limitation, preemptive rights with respect to issuances by
the Company of any securities, including without limitation the Securities, of the Company),
warrants or options to acquire, or instruments convertible into or exchangeable for, any unissued
shares of capital stock or other equity interest in the Company or any Subsidiary, (ii) contracts,
commitments, agreements, understandings or arrangements of any kind to which the Company is a party
or of which the Company has knowledge and relating to the issuance or sale of any capital stock of
the Company or any Subsidiary, or of any such convertible or exchangeable securities or any such
rights, warrants or options, (iii) outstanding securities or instruments of the Company or any
Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become
bound to redeem a security of the Company or any Subsidiary, (iv) securities or other instruments
containing anti-dilution or similar provisions that will be triggered by the issuance of any of the
Securities under this Agreement, or (v) stock appreciation rights or “phantom stock” plans or
agreements or any similar plan or arrangement. No further approval or authorization of any
stockholder, the Board of Directors of the Company or others is required for the issuance and sale
of the Securities. The Company owns the entire equity interest in each of its Subsidiaries, free
and clear of any pledge, lien, security interest, encumbrance, claim or equitable interest, other
than as described in the SEC Filings. The Company has no outstanding indebtedness for borrowed
money and no agreement regarding borrowings, other than pursuant to that certain Loan and Security
Agreement, dated as of July 21, 2005, as amended (the “SVB Indebtedness”). Except as
disclosed in the SEC Filings, there are no shareholder rights plans, stockholders agreements,
voting agreements or other similar agreements with respect to the Common Stock to which the Company
is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.



(e) Legal Proceedings. There is no material action, suit, proceeding, inquiry or
investigation before or by any court, public board, government agency, self-regulatory organization
or body pending or, to the knowledge of the Company, threatened to which the Company or any
Subsidiary is or may be a party or of which the business, property, Common Stock, officers or
directors (in their capacities as such) of the Company or any Subsidiary is subject that is not
disclosed in the SEC Filings, except where the same would not result, either individually or in the
aggregate, in a Material Adverse Effect.



(f) No Violations. Except as disclosed in the SEC filings neither the Company nor any
Subsidiary (i) is in violation of its charter, bylaws, or other organizational document, (ii) is in
violation of any law, administrative regulation, ordinance or order of any court or governmental
agency, arbitration panel or authority applicable to the Company or any Subsidiary, which
violation, individually or in the aggregate, would be reasonably likely to have a Material Adverse
Effect, or (iii) is in default (and there exists no condition which, with the passage of time or
otherwise, would constitute a default) in any respect in the performance of any bond, debenture,
note or any other evidence of indebtedness in any indenture, mortgage, deed of trust or any other
agreement or instrument to which the Company or any Subsidiary is a party or by which the Company
or any Subsidiary is bound or by which the properties of the Company or any Subsidiary are bound,
which would be reasonably likely to have a Material Adverse Effect.



(g) Governmental Permits, Etc. Each of the Company and its Subsidiaries has all necessary
franchises, licenses, certificates and other authorizations from any foreign, federal, state or
local government or governmental agency, department, or body that are currently necessary for the
operation of the business of the Company and its Subsidiaries as currently conducted and as
described in the SEC Filings except where the failure to currently possess any such franchise,
license, certificate or other authorization would not have a Material Adverse Effect.



(h) Intellectual Property. Except as specifically disclosed in the SEC Filings, (i) each of
the Company and its Subsidiaries owns or possesses sufficient rights to use all patents, patent
rights, trademarks, copyrights, licenses, inventions, mask works, trade secrets, trade names,
know-how, moral rights, confidential and proprietary information, compositions of matter, formulas,
designs and proprietary rights (collectively, “Intellectual Property”) described or
referred to in the SEC Filings as owned or possessed by it or that are necessary for the conduct of
its business as now conducted or as described in the SEC Filings, except where the failure to
currently own or possess would not have a Material Adverse Effect, and (ii) to the Company’s
knowledge, neither the Company nor any of its Subsidiaries is infringing, or has received any
notice of or has any knowledge of any asserted infringement by the Company or any of its
Subsidiaries of, any rights of a third party with respect to any Intellectual Property that,
individually or in the aggregate, would have a Material Adverse Effect. To the Company’s
knowledge, there is no claim, action or proceeding being overtly threatened against, but which has
not been made or brought against, the Company or any of its Subsidiaries regarding its Intellectual
Property or infringement of other intellectual property rights which could reasonably be expected
to have, either individually or in the aggregate, a Material Adverse Effect. To the Company’s
knowledge, no third party has any ownership right, title, interest, claim in or lien on any of the
Intellectual Property and the Company has taken, and in the future the Company will use its
reasonable effort to take, all steps reasonably necessary to preserve its legal rights in, and the
secrecy of, all the Intellectual Property. To the Company’s knowledge, there is no material
unauthorized use, infringement or misappropriation of any Intellectual Property of the Company or
any of the Subsidiaries by any third party.



(i) Environmental Matters.



(1) Except as would not reasonably be likely to result in a material liability to the Company,
no underground storage tanks and no amount of any substance that has been designated by any
governmental agency or by applicable federal, state or local law to be radioactive, toxic,
hazardous or otherwise a danger to health or the environment, including without limitation, PCBs,
asbestos, petroleum, urea-formaldehyde and all substances listed as hazardous substances pursuant
to the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended to
date, or defined as a hazardous waste pursuant to the United States Resource Conservation and
Recovery Act of 1976, as amended to date, and the regulations promulgated pursuant to said laws,
but excluding routine quantities of office and janitorial supplies (a “Hazardous
Material”), are present as a result of the actions of the Company, or, to the Company’s
knowledge, as a result of the actions of a third party, in, on or under any property, including the
land and the improvements, ground water and surface water thereof, that the Company or any of its
subsidiaries currently owns, operates, occupies or leases, or to the Company’s knowledge, were
present on any other real property at the time it ceased to be owned, operated, occupied or leased
by the Company as a result of the actions of the Company, or to the Company’s knowledge as a result
of the actions of a third party.



(2) Except as would not reasonably be likely to result in a material liability to the Company
(in any individual case or in the aggregate), neither the Company nor any Subsidiary has
transported, stored, used, manufactured, disposed of or arranged for the disposal of, released or
exposed its employees or others to Hazardous Materials in violation of any federal, state or local
law, rule, regulation, treaty or statute in effect before the Closing Date related to protection of
human health, safety, and the environment, including natural resources (collectively,
“Environmental Laws”).



(3) Except as would not reasonably be likely to result in a material liability to the Company,
the Company and the Subsidiaries currently hold and are in compliance with all approvals, permits,
licenses, clearances and consents required under Environmental Laws for the conduct of the
Company’s and the Subsidiaries’ businesses as currently being conducted.



(4) No action, proceeding, revocation proceeding, amendment procedure, writ, injunction or
claim is pending, or to the Company’s knowledge, threatened, alleging that the Company or any of
the Subsidiaries are in violation of or liable under any Environmental Law.



(j) No General Solicitation; No Integration. Neither the Company nor any other person or
entity authorized by the Company to act on its behalf has engaged in a general solicitation or
general advertising (within the meaning of Regulation D of the Securities Act) of investors with
respect to offers or sales of any of the Securities. The Company has not, directly or indirectly,
sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security
(as defined in the Securities Act) which, to its knowledge, is or will be integrated with the
Conversion Shares and/or the Note sold pursuant to this Agreement.



(k) Interested Party Transactions. Except as set forth in Section 3(k) of the Disclosure
Letter, to the knowledge of the Company, except as set forth in the SEC Filings, no officer or
director of the Company or the Subsidiaries or any “affiliate” or “associate” (as those terms are
defined in Rule 405 promulgated under the 1933 Act) of any such person has had, either directly or
indirectly, a material interest in: (i) any person or entity which purchases from or sells,
licenses or furnishes to the Company any goods, property, technology, intellectual or other
property rights or services; or (ii) any contract or agreement to which the Company is a party or
by which it may be bound or affected.



(l) No Material Adverse Change. Since December 31, 2005, the Company has not experienced or
suffered events or conditions which have, in the aggregate, caused a Material Adverse Effect.



(m) Compliance. The Company’s Common Stock is registered pursuant to Section 12(g) of the
Exchange Act, and the Company has taken no action designed to, or likely to have the effect of,
terminating the registration of the Common Stock under the Exchange Act, nor has the Company
received any notification that the Securities and Exchange Commission (the “SEC”) or the
NASD is contemplating terminating such registration.



(n) No Manipulation of Stock. The Company has not taken and will not, in violation of
applicable law, take any action designed to or that might reasonably be expected to cause or result
in stabilization or manipulation of the price of the Common Stock to facilitate the transactions
contemplated hereby or the sale or resale of the Conversion Shares.



(o) Company not an “Investment Company”. The Company has been advised of the rules and
requirements under the Investment Company Act of 1940, as amended (the “Investment Company
Act”). The Company is not, and immediately after receipt of payment for the Shares will not
be, an “investment company” or an entity “controlled” by an “investment company” within the meaning
of the Investment Company Act and shall conduct its business in a manner so that it will not become
subject to the Investment Company Act.



(p) Brokers or Finders. The Company has not incurred, and shall not incur, directly or
indirectly, any liability for any brokerage or finders’ fees or agents’ commissions or any similar
charges in connection with this Agreement or any transaction contemplated hereby.



(q) Deed of Trust. Except for the recording of a Notice of Intent to Preserve Security
Interest pursuant to California Civil Code Sections 880.310-880.370, after the Deed of Trust (as
defined in Section 6(a) hereof) has been recorded in the Official Records of Santa Clara County,
California, it will not be necessary to re-record, re-register or re-file the Deed of Trust in
order to maintain the priority of the liens and security interests created thereby. There will be
no mortgage taxes or filing fees payable upon the recording and filing of such documents except (i)
normal recording and filing fees payable to the County Recorder of Santa Clara County, California
in connection therewith, (ii) transfer taxes assessed in connection with any transfer of the
Property (as defined in the Deed of Trust) or interest therein, and (iii) any fee or charge payable
to any entity whose services may have been used to assist in such recordation and filing.



(r) Canadian Representations. The Company further represents and warrants to the Purchaser
that, as at the date of issuance of the Note, the Company is not a “reporting issuer” (or the
equivalent) in any Canadian provincial or territorial jurisdiction.



(s) Employee Benefits Plans. The Company does not currently have a guaranteed pension plan
under §§302, 4041, 4042, 4043, 4063, 4065, 4066 and 4068 of ERISA, or a multiemployer plan, under
§§4041A, 4202, 4219, 4242, or 4245 of ERISA.



SECTION 4. Covenants (a) Reasonable Efforts. The parties shall use all reasonable efforts to
timely satisfy each of the conditions described in Sections 5 and 6 of this Agreement.



(b) Consents. The Company will use all reasonable efforts to obtain all consents, approvals,
authorizations or other orders of, or registration, qualification or filing with, any regulatory
body, administrative agency or other governmental body in the United States or any other person
that is required for the execution, delivery and performance of the Transaction Documents,
including without limitation the valid issuance and sale of the Securities to be sold pursuant to
the Transaction Documents. The Purchase will cooperate in good faith in assisting the Purchaser to
fulfill this covenant.



(c) Form D; Blue Sky Laws. The Company shall file a Form D with respect to the Securities as
required under Regulation D and provide a copy thereof to the Purchaser promptly after such filing.
The Company shall take such action at its own cost and expense, as the Company shall reasonably
determine is necessary to qualify the Securities for sale to the Purchaser pursuant to this
Agreement under applicable securities or “blue sky” laws of the states of the United States or
obtain exemption therefrom, and shall provide evidence of any such action so taken to each
Purchaser.



(d) Reservation of Shares. The Company and the Purchaser shall take all commercially
reasonable action necessary to at all times have authorized and reserved for the purpose of
issuance, no less than 100% of the number of shares of Common Stock needed to provide for the
issuance of the Conversion Shares on each Conversion Date.



(1) Redemptions and Dividends. For so long as the Note is outstanding, without the prior
written approval of the Purchaser, the Company shall not repurchase, redeem, or declare or pay any
cash dividend or distribution on, any shares of capital stock of the Company.



(e) No Encumbrance of Property. For so long as the Note is outstanding, without the
prior written approval of the Purchaser, the Company shall not create, incur, assume or suffer to
exist any mortgage, pledge, lien, security interest or other encumbrance of any kind on the
Property (as defined in the Deed of Trust) except for (i) liens for taxes, assessments, fees and
other governmental charges, and for claims the payment of which is not yet overdue or is being
contested in good faith (and for which adequate reserves have been established by the Company on
its books in conformity with GAAP), (ii) statutory liens of landlords, carriers, warehousemen,
processors, mechanics, materialmen or suppliers incurred in the ordinary course of business and
securing amounts not yet due or declared to be due by the claimant thereunder; (iii) liens or
security interests in favor of Purchaser or its affiliates; (iv) zoning restrictions and easements,
licenses, covenants and other restrictions affecting the use of real property that do not
individually or in the aggregate have a material adverse effect on the ability of the Company and
its Subsidiaries to use such real property for its intended purpose in connection with its
business; or (v) matters disclosed in the title insurance report relating to the Property prepared
by First American Title Company in October 2002 in connection with the issuance of the S&F Note.



(f) Regulatory Filings; Reasonable Efforts.



(i) Regulatory Filings. Each of the Company and Purchaser shall coordinate and
cooperate with one another and shall each use all reasonable efforts such that as promptly as
practicable after the date hereof, each of the Company and Purchaser shall make all filings
reasonably determined by the parties to be required by any governmental entity in connection with
the issuance of the Note and the Conversion Shares and the transactions contemplated hereby,
including, without limitation, (i) Notification and Report Forms with the United States Federal
Trade Commission (the “FTC”) and the Antitrust Division of the United States Department of
Justice (“DOJ”) if and as required by the HSR Act, (ii) other comparable filings pursuant
to the merger notification or control laws of any applicable jurisdiction, as agreed by the parties
hereto and (iii) any filings required under the Securities Act, the Exchange Act, any applicable
state or securities or “blue sky” laws and the securities laws of any foreign country, or any other
legal requirement relating to the issuance of the Note and the Conversion Shares. Each of the
Company and Purchaser will cause all documents that it is responsible for filing with any
governmental entity under this Section 4(k) to comply in all material respects with all applicable
legal requirements.



(ii) Exchange of Information. The Company and Purchaser each shall promptly supply
the other with any information that may be required in order to effectuate any filings or
application pursuant to Section 4(k)(i). Except where prohibited by applicable legal requirements,
each of the Company and Purchaser shall consult with the other prior to taking a position with
respect to any such filing, shall consider in good faith the views of one another in connection
with any analyses, appearances, presentations, memoranda, briefs, papers, arguments, opinions and
proposals before making or submitting any of the foregoing to any governmental entity by or on
behalf of any party hereto in connection with any investigations or proceedings in connection with
this Agreement or the transactions contemplated hereby (including under any antitrust or fair trade
legal requirement), coordinate with the other in preparing and exchanging such information and
promptly provide the other with copies of all filings, presentations or submissions (and a summary
of any oral presentations) made by such party with any governmental entity in connection with this
Agreement or the transactions contemplated hereby, provided that with respect to any such filing,
presentation or submission, each of the Company and Purchaser need not supply the other with copies
(or in case of oral presentations, a summary) to the extent that any law, treaty, rule or
regulation of any governmental entity applicable to such party requires such party or its
subsidiaries to restrict or prohibit access to any such properties or information.



(iii) Notification. Each of the Company and Purchaser will notify the other promptly
upon the receipt of (i) any comments from any officials of any governmental entity in connection
with any filings made pursuant hereto and (ii) any request by any officials of any governmental
entity for amendments or supplements to any filings made pursuant to, or information provided to
comply in all material respects with, any legal requirements. Whenever any event occurs that is
required to be set forth in an amendment or supplement to any filing made pursuant to Section
4(k)(i), the Company or Purchaser, as the case may be, will promptly inform the other of such
occurrence and cooperate in filing with the applicable governmental entity such amendment or
supplement.



(iv) Limitation on Divestiture. Notwithstanding anything in this Agreement to the
contrary, nothing contained in this Agreement shall be deemed to require the Company or Purchaser
or any subsidiary or affiliate thereof to agree to any divestiture by itself or any of its
affiliates of shares of capital stock or of any business, assets or property, or the imposition of
any material limitation on the ability of any of them to conduct their businesses or to own or
exercise control of such assets, properties and stock.



SECTION 5. Conditions to the Company’s Obligation to Close The obligation of the Company to issue
and sell the Note to the Purchaser at the Closing is subject to the satisfaction, at or before the
Closing Date, of each of the following conditions, provided that these conditions are for the
Company’s sole benefit and may be waived by the Company at any time in its sole discretion by
providing Purchaser with prior written notice thereof:



(a) Transaction Documents. Purchaser shall have executed each of the Transaction Documents to
which it is a party and delivered the same to First American Title Insurance Company (“Title
Company”), 1737 North First Street, Suite 100, San Jose CA 95112 (other than this Agreement, which
shall have been delivered to the Company), and the Title Company shall have issued or committed to
issue to Purchaser Title Company’s lender’s policy of title insurance (ALTA 1970 form) for
$7,000,000, insuring the first lien priority of the Deed of Trust, such policy of title insurance
to be in conformity with the Proforma Policy attached hereto as Exhibit F, provided that Purchaser
shall be the beneficiary.



(b) Payment of Purchase Price. Purchaser shall have delivered to the Company the purchase
price for the Note being purchased by such Purchaser at the Closing by the Closing Date by wire
transfer of immediately available funds pursuant to the wire instructions attached hereto as
Schedule A.



(c) Representations and Warranties; Covenants. The representations and warranties of the
Purchaser shall be true, correct and complete in all respects as of the date when made and as of
the Closing Date as though made at that time (except for representations and warranties that speak
as of a specific date (which shall be true, correct and complete as of such date)), and the
Purchaser shall have performed, satisfied and complied with in all material respects the covenants,
agreements and conditions required by the Transaction Documents to be performed, satisfied or
complied with by such Purchaser at or prior to the Closing Date.



SECTION 6. Conditions to Purchaser’s Obligation to PurchaseThe obligation of Purchaser
hereunder to purchase the Note from the Company at the Closing is subject to the satisfaction, at
or before the Closing Date, of each of the following conditions, provided that these conditions are
for Purchaser’s sole benefit and may be waived by Purchaser at any time in its sole discretion by
providing the Company with prior written notice thereof:



(a) Transaction Documents. The Company shall have (i) executed each of the Transaction
Documents and delivered the same to the Title Company (other than this Agreement, which shall have
been delivered to the Purchaser), (ii) executed and delivered the Deed of Trust in the form
attached hereto as Exhibit B to the Title Company, for recordation in the Office of the
Recorder of Santa Clara County, and the Title Company shall have issued or committed to issue to
Purchaser Title Company’s lender’s policy of title insurance (ALTA 1970 form) for $7,000,000,
insuring the second lien priority of the Deed of Trust, such policy of title insurance to be in
conformity with the Proforma Policy attached hereto as Exhibit F, provided that Purchaser
shall be the beneficiary, and (iii) executed and delivered the Security Agreement in the form
attached hereto as Exhibit E.



(b) Representations and Warranties; Covenants. The representations and warranties of the
Company shall be true, correct and complete in all respects as of the date when made and as of the
Closing Date as though made at that time (except for representations and warranties that speak as
of a specific date (which shall be true, correct and complete as of such date)) and the Company
shall have performed, satisfied and complied with in all respects the covenants, agreements and
conditions required by the Transaction Documents to be performed, satisfied or complied with by the
Company at or prior to the Closing Date. The Purchaser shall have received a certificate, executed
by the principal financial officer of the Company, dated as of the Closing Date, to the foregoing
effect.



(c) Reservation of Common Stock. As of the Closing Date, the Company shall have reserved out
of its authorized and unissued Common Stock, solely for the purpose of effecting the conversion of
the Note, 1,500,000 shares of its Common Stock and shall have sufficient authorized and unissued
shares of Common Stock to reserve such amount.



(d) Good Standing Certificates. The Company shall have delivered to Purchaser a certificate
evidencing the incorporation and good standing of the Company in Delaware issued by the Secretary
of State of Delaware as of a date within ten days of the Closing Date and a certified copy of the
Company’s articles of organization, certified by the Secretary of State of Delaware, as of a date
within ten days of the Closing Date.



(e) Secretary’s Certificate. The Company shall have delivered to such Purchaser a certificate
of the Secretary of the Company, in the form attached hereto as Exhibit C and dated as of
the Closing Date, certifying as to adoption without subsequent modification or amendment of the
form of resolutions of the Board of Directors of the Company consistent with Section 3(b) of this
Agreement and certifying as to the Company’s certification of incorporation and by-laws, each as in
effect at the Closing.



(f) Filings; Authorizations. The Company shall have made all filings under all applicable
federal and state securities laws necessary to consummate the issuance of the Securities pursuant
to this Agreement in compliance with such laws, except for any filings that may be made after the
Closing.



(g) No Injunctions. No temporary restraining order, preliminary or permanent injunction or
other order or decree, and no other legal restraint or prohibition shall exist which prevents or
arguably prevents the consummation of the transactions contemplated by the Transaction Documents,
nor shall any proceeding have been commenced or threatened with respect to the foregoing.



(h) No Material Adverse Effect. Between the time of execution of this Agreement and the
Closing Date, no Material Adverse Effect shall occur or become known (whether or not arising in the
ordinary course of business).



(i) Approval by the Company’s Board of Directors. The Transaction Documents shall have been
approved by the Board of Directors of the Company, in the form hereof and, if attached as an
Exhibit hereto, in the form so attached, at a general or special meeting in accordance with Company
by-laws, and other requirements.



SECTION 7. Miscellaneous(a) Governing Law; Jurisdiction; Waiver of Jury Trial. This Agreement
shall be deemed to be a contract made under the laws of the State of California, and for all
purposes shall be, governed by, and considered in accordance with, the law of the State of
California. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the state
and federal courts sitting in Santa Clara County, California, for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit,
action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or
proceeding is improper. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof
to such party at the address for such notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. If any provision of this Agreement shall be invalid or unenforceable in any
jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability
of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any
provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY
RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREBY.



(b) Counterparts. This Agreement may be executed in identical counterparts, each of which
shall be deemed an original but all of which together shall constitute one and the same agreement.
This Agreement, once executed by a party, may be delivered to the other parties hereto by facsimile
transmission of a copy of this Agreement bearing the signature of the party so delivering this
Agreement.



(c) Headings. The headings of this Agreement are for convenience of reference only and shall
not limit or otherwise affect the meaning hereof.



(d) Entire Agreement. This Agreement, the Note and the documents referenced herein and
therein constitute the entire agreement among the parties hereto with respect to the subject matter
hereof and thereof. There are no restrictions, promises, warranties or undertakings, other than
those set forth or referred to herein and therein. This Agreement, the Note, the Registration and
Standstill Agreement and the Voting Agreement supersede all prior agreements and understandings
among the parties hereto with respect to the subject matter hereof and thereof.



(e) Amendments. This Agreement may not be modified or amended except pursuant to an
instrument in writing signed by the Company and Purchaser.



(f) Waivers. No provision of this Agreement may be amended or waived other than by an
instrument in writing signed by the Company and the Purchaser. No consideration shall be offered
or paid to any person to amend or consent to a waiver or modification of any provision of this
Agreement unless the same consideration also is offered to all of the parties to this Agreement.



(g) Expenses. Except as otherwise provided herein, the Company and Purchaser shall bear their
own legal and other expenses with respect to this Agreement and the transactions contemplated
hereby.



(h) Notices. Any notices, consents, waivers or other communications required or permitted to
be given under the terms of this Agreement must be in writing and will be deemed to have been
delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile,
provided that such notice is also delivered via regular mail; or (iii) 1 Business Day after deposit
with a nationally recognized overnight delivery service, in each case properly addressed to the
party to receive the same. The addresses and facsimile numbers for such communications shall be:




	 	 	 	If to the Company:






Sipex Corporation




233 South Hillview Drive




Milpitas, CA 95035




Telephone: (408) 934-7547




Facsimile: (408) 935-7678




Attention: Ray Wallin, CFO




	 	 	 	with a copy to:






Wilson Sonsini Goodrich & Rosati




650 Page Mill Road




Palo Alto, CA 94304




Telephone: (650) 493-9300




Facsimile: (650) 493-6811




Attention: Robert G. Day



If to Purchaser, to its address and facsimile number set forth on the signature page hereto
executed by it, with copies to such Purchaser’s representatives as set forth thereon, or at such
other address and/or facsimile number and/or to the attention of such other person as the recipient
party has specified by written notice given to each other party 5 days prior to the effectiveness
of such change. Written confirmation of receipt (A) given by the recipient of such notice,
consent, waiver or other communication, (B) mechanically or electronically generated by the
sender’s facsimile machine containing the time, date, recipient facsimile number and an image of
the first page of such transmission, or (C) provided by a courier or overnight courier service
shall be rebuttal evidence of personal service, receipt by facsimile, receipt from a nationally
recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above,
respectively.



(i) Further Assurances. Each party shall do and perform, or cause to be done and performed,
all such further acts and things, and shall execute and deliver all such other agreements,
certificates, instruments and documents, as the other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the
transactions contemplated hereby.



(j) Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties
hereto and their respective permitted successors and assigns, and is not for the benefit of, nor
may any provision hereof be enforced by, any other person.



(k) Severability. If any provision of this Agreement shall be invalid or unenforceable in any
jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability
of the remainder of this Agreement in that jurisdiction or the validity or enforceability of any
provision of this Agreement in any other jurisdiction.



(l) Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of
the parties and their respective successors and permitted assigns. The Company shall not assign
this Agreement or any rights or obligations hereunder without the prior written consent of the
Purchaser. Purchaser may assign its rights under this Agreement to any person or persons to whom
the Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing
to be bound, with respect to the transferred Securities, by the provisions hereof that apply to the
Purchaser.



(m) Survival. Unless this Agreement is terminated under Section 8(o) of this Agreement, the
representations and warranties of the Company and the Purchaser contained in Sections 2 and 3 of
this Agreement and the agreements and covenants set forth in Sections 3, 4 and 5 of this Agreement
shall survive until such time as no Securities remain outstanding. Purchaser shall be responsible
only for its own representations, warranties, agreements and covenants hereunder.



(n) Publicity. On or promptly following the Closing Date, the Company shall file a Form 8-K
describing the terms of the transactions contemplated by the Transaction Documents in the form
required by the 1934 Act, and attaching the material Transaction Documents (including all
attachments, the “8-K Filing”). Subject to the foregoing, neither the Company nor
Purchaser shall issue any press releases or any other public statements with respect to the
transactions contemplated hereby; provided, however, that the Company shall be entitled, without
the prior approval of Purchaser (although the Purchaser shall be consulted by the Company in
connection with any such press release prior to its release and shall be given the opportunity to
review its contents), to make any press release or other public disclosure with respect to such
transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith and
(ii) as is required by applicable law and regulations. Each of the Company and the Purchaser shall
have the right to approve before issuance any press releases or any other public statements by the
other party with respect to the transactions contemplated by the Transaction Documents.



(o) Termination. In the event that the Closing shall not have occurred with respect to the
Purchaser on or before 30 Business Days from the date hereof due to the Company’s or such
Purchaser’s failure to satisfy the conditions set forth in Sections 6 and 7 of this Agreement (and
the nonbreaching party’s failure to waive such unsatisfied conditions), the nonbreaching party
shall have the option to terminate this Agreement with respect to such breaching party at the close
of business on such date without liability of any non-breaching party to any other party, and the
Company shall return any and all funds paid hereunder to the Purchaser no later than the close of
business on the Business Day following such termination; provided, however, that if this Agreement
is terminated pursuant to this Section 8(o).



(p) Remedies. Purchaser and each holder of the Securities shall have all rights and remedies
set forth in the Transaction Documents and all rights and remedies which such holders have been
granted at any time under any other agreement or contract and all of the rights which such holders
have under any law. Any person having any rights under any provision of this Agreement shall be
entitled to enforce such rights to recover damages by reason of any breach of any provision of this
Agreement and to exercise all other rights granted by law. Furthermore, the Company recognizes
that in the event that it fails to perform, observe, or discharge any or all of its obligations
under this Agreement, any remedy at law may prove to be inadequate relief to the Purchaser. The
Company therefore agrees that the Purchaser shall be entitled to seek temporary and permanent
injunctive relief in any such case without the necessity of proving actual damages and without
posting a bond or other security.



3




IN WITNESS WHEREOF, the parties have caused this Securities Purchase Agreement to be
duly executed as of the date first written above.



	 
	 

	“COMPANY”

	 

	SIPEX CORPORATION

	 

	 

	By: /s/ Ralph Schmitt

	 

	 

	Name: Ralph Schmitt

	 

	 

	Title: Chief Executive Officer and President

	 







[Signature of the Purchaser on Following Page]




4



	 
	 

	“PURCHASER”

	 

	RODFRE HOLDINGS LLC

	 

	By: /s/ Joseph Prudente

	 

	 

	(signature of authorized representative)

	 

	Name: Joseph Prudente

	 

	 

	Its: Director

	 

	 

	Address: 41 Main Street, Bolton, MA, 01740

	 

	 

	Telephone: (978) 779-3000

	 

	 

	Fax: (978) 779-3050

	 

	 

	Tax I.D. or SSN: 47-0935666







5




EXHIBIT A




FORM OF NOTE




6




 EXHIBIT B




7




FORM OF DEED OF TRUST

EXHIBIT C




8




SECRTARY’S CERTIFICATE

SCHEDULE A




WIRE INSTRUCTIONS




	 	 	 	 	 
	BANK:
	 	FC-Silicon Valley Bank

	 
	 	 	 	 
	 
	 	3003 Tasman Drive
	 
	 	 	 	 
	 
	 	Santa Clara, CA  95054  USA

	ACCOUNT NAME:
	 	Sipex Corporation

	 
	 	 	 	 
	ACCOUNT NUMBER:
	 	 	3300439362	 
	 
	 	 	 	 
	ROUTING AND TRANSIT #:
	 	 	121140399	 
	 
	 	 	 	 
	SWIFT CODE:
	 	SVBKUS6S

	 
	 	 	 	 







9